Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma

Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma

Abstract Background and aim Although antiviral treatments have been shown to affect the recurrence and long-term survival of patients with hepatocellular carcinoma (HCC) who have high viral loads, the effect of different responses to antiviral therapy on the clinical outcomes remains unclear. This s...

Full description

Bibliographic Details
Main Authors: Peng Wang, Xinhui Wang, Xiaoli Liu, Fengna Yan, Huiwen Yan, Dongdong Zhou, Lihua Yu, Xianbo Wang, Zhiyun Yang
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma
Antiviral treatment
Primary non-response
Hepatitis B virus
Online Access:https://doi.org/10.1186/s12885-023-11059-y

Internet

https://doi.org/10.1186/s12885-023-11059-y

Similar Items